Translatum Medicus
Translatum Medicus


Toronto, ON, Canada

Translatum Medicus Inc is a preclinical drug development company focused on macrophage modulation to treat blinding eye disease, with a patented lead drug candidate, TMi-018 for the treatment of dry Age-Related Macular Degeneration (AMD). Translatum is based in the Johnson & Johnson Innovation Incubator JLABS@Toronto, and has been increasingly gaining traction as one of the most innovative early stage ophthalmic biotech companies.

Something looks off?
Open jobs at Translatum Medicus
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.